Description
Our objective is to examine “coverage, price, and reimbursement” (“CPR”) for multigene tests broadly and for cancer-related indications, specifically, why tests are covered/not covered by payers, how this is changing over time, and how CPR influences testing decisions and practices in clinic settings.
Prime PI is Kathryn A. Phillips, Ph.D., UCSF. Site PI is Su-Ying Liang, Ph.D.
Principal Investigator
Funder
National Institutes of Health - National Cancer Institute
Start Date
July 01, 2018
End Date
June 30, 2021
Related Studies
Advance Care Planning Practices in Caring for Vulnerable Elders with Multiple Chronic Conditions
Investigator(s): Ellis C. Dillon, Ph.D.
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS
Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator
Improving Cancer Care
Investigators: Harold (Hal) Luft, Ph.D., Ellis C. Dillon, Ph.D., Su-Ying Liang, Ph.D.
Latinas' Experiences of Breast Cancer Treatment in Santa Cruz County
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., Harold (Hal) Luft, Ph.D., External PI, Principal Investigator
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Investigators: Sukyung Chung, Ph.D., Jiang Li, Ph.D., MPH, Dorothy Hung, Ph.D., M.A., MPH